Patients who keep missing treatment goals despite good therapy may be facing an unrecognized hormonal driver that primary care is now positioned to catch early.
Recognizing Hypercortisolism in Patients with Type 2 Diabetes in Primary Care
The panel of experts examines how the CATALYST trial is changing the way primary care clinicians recognize hypercortisolism in patients with difficult-to-control type 2 diabetes.
Advertisement
Advertisement
Trending on Patient Care Online
1
New Childhood Vaccine Executive Order Draws Criticism From AAP, AMA, NFID
2
Once-Weekly Insulin Icodec Enters US Market for Adults With Type 2 Diabetes
3
Three Midlife Vascular Risk Factors Linked to 13 Fewer Dementia-Free Years in New Study
4
Recognizing Hypercortisolism in Primary Care
5